Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

Short descriptor: Inj., zirabev, 10 mg

✓ Active HCPCS Level II 2026
Open Q5118 in the app →

Look up Q5118 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5118 is the HCPCS Level II code for Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2019-10-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5118 with the canonical source and edition:

Q5118 — Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5118

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5118

Related Codes in Section Q

← Q5117 Inj., kanjinti, 10 mg Q5119 → Inj ruxience, 10 mg
Q5114 Inj ogivri 10 mg Q5115 Inj truxima 10 mg Q5116 Inj., trazimera, 10 mg Q5117 Inj., kanjinti, 10 mg Q5119 Inj ruxience, 10 mg Q5120 Inj pegfilgrastim-bmez 0.5mg Q5121 Inj. avsola, 10 mg Q5122 Inj, nyvepria Q5123 Inj. riabni, 10 mg Q5124 Inj. byooviz, 0.1 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial